Jintian Pharmaceutical Group Limited provided earnings guidance for the six months ended June 30, 2014. For the six months, the company expects to record a substantial increase in its consolidated net profit for the six months ended 30 June 2014 as compared to that for the corresponding period in 2013, which is mainly attributable to a substantial growth in both the retail and distribution businesses.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.077 HKD | +4.05% | -1.28% | -22.22% |
06-13 | Universal Health International to Raise Over HK$10.0 Million via Share Subscriptions | MT |
02-28 | Universal Health International Group's Fiscal H1 Loss Narrows | MT |
1st Jan change | Capi. | |
---|---|---|
-22.22% | 6.33M | |
+29.50% | 78.4B | |
+0.30% | 25.12B | |
+14.70% | 8.62B | |
+2.20% | 8.55B | |
-28.87% | 6.91B | |
+16.06% | 5.34B | |
+1.58% | 4.17B | |
-8.90% | 3.82B | |
-7.62% | 3.37B |
- Stock Market
- Equities
- 2211 Stock
- News Universal Health International Group Holding Limited
- Jintian Pharmaceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2014